Company intelligence / Profile preview

Genomics BioSci & Tech

Ownership: Private
Employees: ~26
Development stage: Commercial

Overview

Genomics BioSci & Tech is the largest commercial genome sequencing company in Taiwan. It offers comprehensive genomic analysis platforms and critical technologies for researchers and medical institutions. The company provides sequencing, synthesis (oligonucleotides/peptides), genomic/proteomic analysis, reproductive health/cancer testing services, as well as contract development/manufacturing for nucleic acid-based APIs and vaccine adjuvants[1][3][4][5].

Therapeutic areas: OncologyWomen's Health
Modalities: OligonucleotidePeptideGene therapy (support services)Vaccine (adjuvant/API development support)
Industry: Molecular Diagnostics

Partnerships

Academia Sinica’s Genomic Research CenterNational Taiwan Ocean UniversityMiTac Information Technology Corp.CDC Taiwan

Beyond the preview

Go deeper on Genomics BioSci & Tech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genomics BioSci & Tech.

Explore the full profile